Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DENND1C | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
mRNA | BOLA3 | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
mRNA | SLC7A3 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
mRNA | TMEM262 | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
mRNA | GPR12 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
mRNA | RNF44 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
mRNA | NTNG2 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
mRNA | SMURF2 | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
mRNA | STX6 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
mRNA | KIFC1 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |